SCHEMBL2824312

SCHEMBL2824312

CCCCC(CCCC)C1=CC=CCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13696257 0.80 MAPT (0.33)
SCHEMBL29210917 0.79
SCHEMBL6911323 0.77 DNM1 (0.37)
SCHEMBL19788213 0.73
SCHEMBL6676488 0.72 DNM1 (0.30)
SCHEMBL20537330 0.72
SCHEMBL10336627 0.72 CYP3A4 (0.36)
SCHEMBL10335910 0.72 TSHR (0.31)
SCHEMBL10335962 0.72 TP53 (0.32)
SCHEMBL10335960 0.72 ALDH1A1 (0.36)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1170004-B1 PREPARATIONS FOR PERCUTANEOUS ABSORPTION HISAMITSU PHARMACEUTICAL CO (JP) 2010-10-27 EP disclosed
US-7504114-B1 Oxybutynin or fentanyl in a nonaqueous liquid having a solubility parameter of 7 to 13 (cal/cm3)1/2 and acetic acid or an acetate (sodium acetate); patches; excellent skin permeability HISAMITSU PHARMACEUTICALS (JP) 2009-03-17 US disclosed
EP-1170004-A1 PREPARATIONS FOR PERCUTANEOUS ABSORPTION HISAMITSU PHARMACEUTICAL CO., INC. (JP) 2002-01-09 EP disclosed